Zetzl, Teresa http://orcid.org/0000-0002-6326-0702
Pittig, Andre
Renner, Agnes
van Oorschot, Birgitt
Jentschke, Elisabeth
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 11 November 2020
Accepted: 6 June 2021
First Online: 22 June 2021
Declarations
:
: The investigation conforms to the principles outlined in the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of the University Würzburg on 15/05/2018 (Nr. 59/18 sc). Eligible patients received written information about all relevant aspects of the study and that their participation in the study is voluntary and they have the right to refuse or to withdraw their consent at any time without reprisals. Patients provided written informed consent. The study has been registered with the German Clinical Trials Register DRKS00016034 and Clinical Trials.gov NCT04433793.
: The design, conduct, data collection, analysis, and interpretation of the results were performed independently of the funders. The funders played no role in the review or approval of this manuscript.
: Zetzl and Renner report grants from Deutsche Krebshilfe/German Cancer Aid, during conduct of the study. The authors declare no competing interests.